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EXPANDED MAINE DRUG DEATH REPORT FOR 2018 
Updated 4/19/19 
Marcella H. Sorg, PhD 
Margaret Chase Smith Policy Center 
University of Maine 
This report, funded by the Maine Office of Attorney General, provides a summary of statistics 
regarding drug fatalities in Maine during 2018.  Data for the report were collected at the Office of 
Chief Medical Examiner. A drug death is identified when one or more drugs are mentioned on the 
death certificate as a cause or significant contributing factor for the death.  
Executive Summary 
There has been a reduction in 2018 drug deaths compared to 2017, 15% fewer drug 
deaths overall, with a reduction in both non-pharmaceutical and pharmaceutical opioid deaths.  
There were 354 total drug deaths statewide, down from 417 in 2017, and similar to 2016 levels.  
Of these 354 deaths, 80% were caused by opioids, frequently in combination with other drugs or 
alcohol.    
Maine is not the only state seeing a reduction in overdoses. The across-the-board 
reduction in both pharmaceutical and non-pharmaceutical drug deaths suggests broad influences 
are impacting overdose rates, for example, economic changes, the composition and combination 
of drugs being trafficked, and regional law enforcement efforts, as well as specific policy 
changes around opioids. 
Figure 1 shows the changes in major categories over time.  Non-pharmaceutical opioid 
deaths, including fentanyl, fentanyl analogs, and heroin, have declined by 18%.  Pharmaceutical 
opioid deaths, predominantly oxycodone, hydrocodone and methadone, declined by 37%.   
It is important to point out that the reduction in deaths may represent a decline in the 
lethality of specific drugs and how they are being used. It does not necessarily indicate a 
reduction in the numbers of individuals with opioid use disorder. Patterns of use may be 
changing. For example, Maine has seen an increase in the number of deaths involving cocaine 
over the past several years, and a small, but dramatic increase in 2018 in the number of deaths 
caused by methamphetamine.  Heroin deaths have decreased, but the statistics on arrests by the 
Maine Drug Enforcement Agency suggest that heroin availability has not decreased. 
This year we are presenting data for all counties, regardless of the number of their total 
drug deaths.  These totals are much smaller than the statewide total and because of those small 




Figure 1.  Overall trends in Maine drug death categories. Note that categories are not mutually exclusive. 
 
  
2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Non-Opioid 49 40 40 42 36 43 34 61 65 71
Pharm. Opioid 120 123 108 103 107 111 112 123 124 78
Pharm + Non-Pharm Opioid 2 4 0 10 7 24 31 51 53 26



















• Total: In 2018 there were 354 drug-induced deaths statewide, which is 42 (15%) fewer than 
in 2017. Of the 354 total, 283 (80%) deaths were caused by opioids alone or in combination 
with other drugs and/or alcohol. 
  
• Manners of death: Of the 354 drug deaths, 313 (89%) were accidental1 overdoses, 30 (8%) 
were suicides, and 10 (3%) were certified as undetermined manner of death.  
 
• Overall patterns of note in 2018:  
o Most (80%) drug deaths were caused by two or more drugs. The average cause of 
death involved 3 drugs. This is about the same proportion as in 2017. 
o Deaths due to opioids totaled 283, a 20% reduction in number compared to 2017. 
o Deaths due to non-pharmaceutical opioids such as illicit fentanyl and heroin totaled 
231, (82% of opioid deaths), an 18% reduction in number compared to 2017.  
o Deaths due to pharmaceutical opioids totaled 78 (28% of opioid deaths), a 37% 
reduction in number compared to 2017. 
o Fentanyl and its analogs caused 217 deaths (77% of opioid deaths), a 12% reduction 
in number compared to 2017. 
o Heroin caused 74 deaths (26% of opioid deaths), a 16% reduction in number 
compared to 2017.  
o Cocaine-involved deaths totaled 90 (25% of drug deaths), a 1% reduction in number 
compared to 2017. Cocaine is a co-intoxicant in 32% of fentanyl deaths and 32% of 
heroin deaths. 
o Deaths due to methamphetamine totaled 26, a 62% increase from 16 in 2017. 
 
• Demographic patterns:  
 
Table 1. Demographic patterns by manner of death, 2018 
 Total Average Age Age Range Percent Male 
All drug deaths 354 42 0-90 253 (71%) 
Accidents 314 41 0-73 230 (73%) 
Suicides 30 50 18-90 17 (57%) 
 
  
                                                        




• Involvement of specific drug categories: 
 
Table 2. Frequency of specific drug categories, 2018 
Specific drug or drug category causing the death (alone or in 
combination with other drugs and/or alcohol) 
 
Number 
Percent of 354 
drug deaths 
Number of deaths caused by more than one drug 284 80% 
Any pharmaceutical drug 198 56% 
Any opioid (pharmaceutical or non-pharmaceutical) 283 80% 
Naloxone present in the toxicology report*  97 27% 
Any illicitly manufactured drug (includes heroin/morphine, non-
pharmaceutical fentanyl, fentanyl analogs, other illicitly-manufactured 







Any non-pharmaceutical opioid drugs (heroin/morphine, fentanyl, fentanyl 





Heroin/morphine and/or fentanyl or fentanyl analogs 230 65% 
Fentanyl and/or fentanyl analogs (known pharmaceutical fentanyl removed) 217 61% 
Heroin/morphine (known pharmaceutical morphine removed) 74 21% 
Any pharmaceutical opioid (most were not prescribed to the decedent) 78 22% 
Any benzodiazepine 78 22% 
Cocaine 90 25% 
Methamphetamine 26 7% 




• County/City frequencies: The following table provides totals for the counties and the six 
cities that had 10 or more drug deaths in 2018.  
 





















Androscoggin 33 (9%) 26 (9%) 8% 
        Lewiston 16 (5%) 13 (5%) 3% 
Aroostook 8 (2%) 4 (1%) 5% 
Cumberland 88 (25%) 70 (25%) 22% 
         Portland 44 (12%) 34 (12%) 5% 
Franklin 5 (1%) 5 (2%) 2% 
Hancock 10 (3%)  9 (3%) 4% 
Kennebec 43 (12%) 38 (13%) 9% 
         Augusta 15 (4%) 14 (5%) 1% 
Knox 6 (2%) 3 (1%) 3% 
Lincoln 6 (2%) 4 (1%) 3% 
Oxford 13 (4%) 9 (3%) 4% 
Penobscot 53 (15%) 39 (14%) 11% 
         Bangor 24 (7%) 18 (6%) 2% 
Piscataquis 5 (1%) 5 (2%) 1% 
Sagadahoc 2 (1%) 0 (0%) 3% 
Somerset 10 (3%) 9 (3%) 4% 
Waldo 9 (3%) 6 (2%) 3% 
Washington 9 (3%) 8 (3%) 2% 
York 54 (15%) 48 (17%) 15% 









• Heroin/morphine deaths include any death in which the cause of death identifies “heroin” or 
“morphine.”  We have removed all cases involving known pharmaceutical morphine, so the 
heroin/morphine deaths are all suspected heroin overdoses. In 2018 there were 74 deaths due 
to (non-pharmaceutical) heroin/morphine alone or in combination with other drugs.  This is a 
16% decrease from the 88 heroin/morphine deaths identified in 2017. 
o 57 (77%) are male and 17 (23%) are female. 
o Average age of heroin/morphine deaths is 38 (age range 1-69). 
 
• Involvement of co-intoxicant drugs in heroin/morphine deaths: 
 
Table 4. Frequency of co-intoxicant drugs involved in heroin/morphine deaths, 2018 
 
 
Specific co-intoxicants in addition to heroin/morphine 





















Non-pharmaceutical fentanyl and/or at least one fentanyl 





Alcohol in addition to heroin/morphine 21 28% 
At least one benzodiazepine in addition to heroin/morphine 14 19% 




Non-Pharmaceutical (“Illicit”) Fentanyl and/or Fentanyl Analog Deaths 
 
• This category includes deaths caused by non-pharmaceutical (illicitly manufactured) fentanyl 
or fentanyl analogs. We removed all cases that involved known pharmaceutical fentanyl from 
these totals. There were 217 overdoses due to non-pharmaceutical fentanyl and/or fentanyl 
analogs in 2018. This is a 12% decrease from 247 deaths in 2017. 
o 169 (78%) are male and 48 (22%) are female. 
o The average age in illicit fentanyl/fentanyl analog deaths is 38 (age range 1-69). 
 
• Involvement of co-intoxicant drugs in non-pharmaceutical fentanyl deaths: 
 
Table 5.  Frequency of co-intoxicant drugs involved in fentanyl deaths, 2018 
 
 
Specific co-intoxicants in addition to fentanyl and/or 









FENTANYL and FENTANYL ANALOG 
COMBINATIONS 
  
• Fentanyl (with or without fentanyl analogs) 207 95% 
• Fentanyl analogs (with or without fentanyl) 65 30% 






CO-INTOXICANTS IDENTIFIED IN FENTANYL and/or 
FENTANYL ANALOG DEATHS 
  
• One or more drugs (or alcohol) in addition to fentanyl 





• One or more pharmaceutical opioids in addition to 











• Alcohol in addition to fentanyl and/or fentanyl analogs 59 27% 
• One or more benzodiazepines in addition to fentanyl 





• Cocaine in addition to fentanyl and/or fentanyl analogs 69 32% 
 
• Fentanyl analogs identified: 
 
Table 6.  Frequency of fentanyl analogs identified as a cause of death in 2018 
 
Fentanyl Analog Identified 










Acetyl Fentanyl 48 74% 
Carfentanil 1 2% 
Cyclopropyl Fentanyl 2 3% 
Furanyl Fentanyl 2 3% 
Methoxyacetyl Fentanyl 4 6% 
Parafluorobutyryl Fentanyl 3 5% 
Parafluoroisobutyryl Fentanyl 10 15% 
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Figure 2.  Number of drug-induced deaths in Maine, with subtotals for deaths caused by any pharmaceutical 
drugs and for deaths caused by any illicit (non-pharmaceutical) drugs.  Most deaths are caused by more than one 
drug.  Pharmaceutical and illicit drugs may be combined to cause death.  Note: 2017 total was revised from 418 
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Figure 3. Comparison of the number deaths due to pharmaceutical versus non-pharmaceutical opioids, alone or 





Figure 4. Total drug deaths with subtotals for the number of deaths due to heroin/morphine and non-
pharmaceutical fentanyl and/or its analogs.  Although separate totals are provided for heroin/morphine and 
fentanyl/fentanyl analog fatalities, many deaths include both drug categories.  
2010 2011 2012 2013 2014 2015 2016 2017 2018
Total 167 155 163 176 208 272 376 417 354
Pharm Opioid 123 108 103 107 111 112 123 124 78











Total Deaths due to Pharmaceutical Opioids Compared to 
Non-Pharmaceutical (Illicit) Opioids, Alone or in 
Combination
2010 2011 2012 2013 2014 2015 2016 2017 2018
Total 167 155 163 176 208 272 376 417 354
Heroin/Morphine 8 7 28 40 57 107 120 88 74











Deaths due to Heroin/Morphine and Non-Pharmaceutical 






Figure 5.  Total deaths due to heroin/morphine (“HM”) with non-pharmaceutical fentanyl (Non-pharm Fent”) 
and/or its analogs, alone or in combination with each other. 
 
2010 2011 2012 2013 2014 2015 2016 2017 2018
Non-pharm Fent, without Heroin 0 0 0 0 21 50 119 193 156
HM, without Non-pharm Fent 8 7 28 39 46 70 45 34 13








Deaths Due to Heroin/Morphine (HM) and Non-
Pharmaceutical Fentanyl and/or its Analogs, Alone or in 
Combination with Each Other 
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Figure 6.  Number of deaths caused by key pharmaceutical opioids, alone or in combination with other drugs. 
Note that these fentanyl cases are pharmaceutical fentanyl. 
 
2010 2011 2012 2013 2014 2015 2016 2017 2018
Oxycodone 47 35 45 34 42 37 46 53 29
Methadone 51 43 32 38 30 38 41 31 19
Buprenorphine 5 3 5 7 7 9 12 22 14
Hydrocodone 17 17 10 10 18 17 18 9 12
(Pharm.) Fentanyl 10 16 10 9 10 6 3 3 2












Figure 7.  Number of deaths caused by cocaine, alone or in combination with other drugs 
2010 2011 2012 2013 2014 2015 2016 2017 2018
Cocaine 11 14 13 10 24 35 60 91 90
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